Trials / Completed
CompletedNCT00721903
Three Dimensional (3D) Ultrasound in Predicting Response to Breast Cancer Therapies
3D Breast Ultrasound In Predicting Response to Breast Cancer Therapies
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 88 (actual)
- Sponsor
- University of Michigan · Academic / Other
- Sex
- Female
- Age
- 25 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine how well changes can be determined in malignant masses from ultrasound scans.
Detailed description
To evaluate the proportions of correct diagnosis of response to breast Cancer therapies for localized breast cancer by ultrasound. To develop a model based on patient characteristics, physical exam, and radiologic studies which will predict the possibility that a patient has had a complete pathological response to chemotherapy neoadjuvant therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Ultrasound Scan | 10 female volunteers with normal breast who will be studied to refine imaging techniques and for comparison with patients. To the degree possible, the volunteer group will be age-matched to patients with symptoms, initially 30 to 70 years of age. |
| PROCEDURE | Mammography and Ultrasound | To determine how well from ultrasound scans, changes in malignant masses can be measured, and to whether the use of a dye visible by ultrasound will be useful in evaluating different therapies for breast cancer. |
Timeline
- Start date
- 2000-03-01
- Primary completion
- 2014-09-01
- Completion
- 2014-09-01
- First posted
- 2008-07-25
- Last updated
- 2016-05-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00721903. Inclusion in this directory is not an endorsement.